Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2011 10
2012 11
2013 9
2014 4
2015 6
2016 2
2017 6
2018 7
2019 6
2020 5
2021 8
2022 7
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Blood Pressure Control in Patients with Diabetic Kidney Disease.
Kim Y, Kim W, Kim JK, Moon JY, Park S, Park CW, Park HS, Song SH, Yoo TH, Lee SY, Lee EY, Lee J, Jin K, Cha DR, Cha JJ, Han SY; Korean Diabetic Kidney Disease Working Group. Kim Y, et al. Among authors: kim jk. Electrolyte Blood Press. 2022 Dec;20(2):39-48. doi: 10.5049/EBP.2022.20.2.39. Epub 2022 Dec 30. Electrolyte Blood Press. 2022. PMID: 36688208 Free PMC article. Review.
Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis.
Kim JH, Park JY, Jang SH, Kim JK, Song YR, Lee HS, Kim SG. Kim JH, et al. Among authors: kim jk. Allergy Asthma Immunol Res. 2021 May;13(3):517-519. doi: 10.4168/aair.2021.13.3.517. Allergy Asthma Immunol Res. 2021. PMID: 33733645 Free PMC article. No abstract available.
Gallbladder lymphangioma: a case report and review of the literature.
Kim JK, Yoo KS, Moon JH, Park KH, Chung YW, Kim KO, Park CH, Hahn T, Park SH, Kim JH, Jeon JY, Kim MJ, Min KS, Park CK. Kim JK, et al. World J Gastroenterol. 2007 Jan 14;13(2):320-3. doi: 10.3748/wjg.v13.i2.320. World J Gastroenterol. 2007. PMID: 17226918 Free PMC article. Review.
78 results